A detailed history of Cornerstone Planning Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 14 shares of INCY stock, worth $1,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Holding current value
$1,038
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$65.08 - $83.38 $911 - $1,167
14 New
14 $1.02 Million
Q3 2023

Nov 08, 2023

BUY
$57.77 - $65.93 $57 - $65
1 New
1 $58,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.